Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Cobicistat-containing Regimens in HIV-1 with Renal Impairment
NCT01363011Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- May 2011
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of cobicistat in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Gilead Sciences. Started May 2011; status: completed.
02
Drugs
cobicistat
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01363011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01363011.